Overview

Study to Determine the Effect of an Anti-IgE Agent on Inflammatory Cells in the Skin of Atopic Dermatitis Patients

Status:
Completed
Trial end date:
2003-04-01
Target enrollment:
Participant gender:
Summary
Elevated levels of immunoglobuline E in blood are said to promote the occurence of atopic dermatitis; in fact, many patients with atopic dermatitis have high IgE levels. This study tried to explore whether the depletion of IgE from blood and skin might result in a change of immunological parameters and might alter the clinical course of the disease.
Phase:
Phase 4
Details
Lead Sponsor:
Medical University of Vienna
Treatments:
Omalizumab